Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026

Alliance in Immunohistochemical Testing

By HospiMedica staff writers
Posted on 31 Jan 2002
A collaboration to develop and market reagent kits and antibodies used in immunohistochemical (IHC) testing worldwide has been announced by ChromaVision Medical Systems, Inc. More...
(San Juan Capistrano, CA, USA) and Richard-Allan Scientific Company (Kalamazoo, MI, USA).

Richard-Allan will manufacture antibodies and reagents for ChromaVision to market along with its Automated Cellular Imaging System (ACIS), which combines color-based imaging technology with automated microscopy. The combination of specialized reagent kits and the ACIS digital microscope system will provide laboratory and pathology customers with an integrated laboratory testing tool to address the growing need for standardized, quantifiable IHC testing information. Reagent kits that support tests most frequently performed by customers on the ACIS system are expected to be available in the near future, followed by a full suite of kits that support all tests performed using the system.

"Richard-Allan Scientific is the worldwide leader in reagent, consumable, and equipment sales to the anatomical pathology market, while the ChromaVision ACIS has emerged as the most widely used imaging system in clinical practice,” said Carl W. Apfelbach, president and COO of ChromaVision. "This alliance provides a unique sales growth opportunity for both companies.”




Related Links:
Richard-Allan
ChromaVision

Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Electrolyte Analyzer
CBS-4000 (CBS-400)
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.